Track topics on Twitter Track topics that are important to you
COLORADO SPRINGS, Colo., July 24, 2015 (GLOBE NEWSWIRE) -- Vectrus, Inc. (NYSE:VEC), will announce its 2015 second-quarter financial results on Wednesday, Aug. 5, 2015, after market close.
Management representatives will conduct an investor briefing and conference call at 8 a.m. EDT on Thursday, Aug. 6, 2015.
U.S.-based participants may dial in to the conference call at 888-572-7033, while international participants may dial 719-325-2361. Passcode for both is 9661551. For all other listeners, a live webcast of the briefing and conference call will be available on the Vectrus Investor Relations website at http://investors.vectrus.com.
A replay of the briefing will be posted on the Vectrus website shortly after completion of the call, and will remain available for one year. A telephonic replay will also be available through Aug. 20 at 877-870-5176 (domestic) or 858-384-5517 (international) with passcode 9661551.
Vectrus is a leading, global government services company with a history in the services market that dates back more than 70 years. The company provides infrastructure asset management, information technology and network communication services, and logistics and supply chain management services to U.S. government customers around the world. Vectrus is differentiated by operational excellence, superior program performance, a history of long-term customer relationships, and a strong commitment to their mission success. Vectrus is headquartered in Colorado Springs, Colo., and includes more than 5,000 employees spanning 85 locations in 15 countries. In 2014, Vectrus generated sales of $1.2 billion. For more information, visit our website at www.vectrus.com or connect with us on Facebook, Twitter, LinkedIn, and YouTube.
CONTACT: Investors: Mike Smith 719-637-5773 firstname.lastname@example.org Media: George Rhynedance 719-637-4182 email@example.comNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...